Accent Therapeutics Presents Data Supporting DHX9 Inhibition as a Novel Therapeutic Modality at American Association for Cancer Research (AACR) Annual Meeting 2023

Data support DHX9 inhibition as a novel therapeutic modality in microsatellite instable colorectal cancer and describe the first identification of potent and selective small molecule inhibitors of DHX9 Proprietary crystal structures of DHX9 enable rapid, structure-based drug discovery for…